Ledger.Open graph →
SEC Form D · filed November 20, 2020

Urigen Pharmaceuticals, Inc

Offering
$3.0M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BOUND BROOK, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Dan Vickery · Bound Brook, NJExec · DirectorC. L. Parsons · North Brunswick, NJDirectorCarlo L. Di Fonzo · Bound Brook, NJDirectorRobert L. Evans · Bound Brook, NJDirectorDan Vickery · Bound Brook, NJExec · DirectorC. L. Parsons · North Brunswick, NJDirectorCarlo L. Di Fonzo · Bound Brook, NJDirectorRobert L. Evans · Bound Brook, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗